The Wall Street Journal published recently an article called “IVF Testing Spurs a Debate Over Mosaic Embryos” with the opinion of different specialists in the IVF field.
In words of Prof. Simón, our CSO, “Igenomix, tests embryos for about 200 U.S. clinics. Roughly 80% of those clinics classify embryos as either normal or abnormal and don’t want to know if one tests mosaic”.
Access to the full article here